Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Background Most head and neck cancers (HNCs), specifically squamous cell carcinoma, express epidermal growth factor and are associated with an inadequate response to radiotherapy and chemotherapy. Anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAb) increase response rates and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Thai Hoa, Nguyen Thi, Quang Huy, Huynh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228796/
https://www.ncbi.nlm.nih.gov/pubmed/32426197
http://dx.doi.org/10.7759/cureus.8105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228796/
https://www.ncbi.nlm.nih.gov/pubmed/32426197
http://dx.doi.org/10.7759/cureus.8105

Ejemplares similares